MarketPeel
Insider Trading Intelligence
MP

Mark Plavsic

FATE
CHIEF TECHNICAL OFFICER · FATE THERAPEUTICS INC · CIK 0001868719
FILING MIX · LIFETIME60%/40%
BUYS
9
SELLS
6
TOTAL VALUE
$356.3K
COMPANIES
2
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
236,366
AVG SELL PX
$7.97
TRADE KIND
SHOWING 15 / 15
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mark Plavsic, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+33.33%+2.14%+0.05%+2.09%+2.49%
14d6+50.00%+4.46%+0.27%+4.19%+2.58%
30d6+50.00%+4.81%+0.68%+4.13%+3.97%
60d6+66.67%-3.56%-0.15%-3.41%-10.39%
90d6+83.33%-7.31%+2.12%-9.44%-19.00%
180d6(1 pending)+80.00%-23.67%+3.65%-27.32%-21.61%
1y6(2 pending)+100.00%-43.45%+17.13%-60.58%-50.24%
2y6(4 pending)+100.00%-79.36%+51.99%-131.35%-131.35%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FATE · 123,705 shares · as of Jan 10, 2023
032,71165,42198,132130,84220222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 9 buys / 6 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
62,339243,736Mar 2, 2026Mar 3, 2026View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
112,661112,661Mar 2, 2026Mar 3, 2026View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Technology Officer
15,890$5.05$80.2K181,397Feb 17, 2026Feb 17, 2026View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Technology Officer
12,169$6.35$77.3K197,287Oct 16, 2025Oct 16, 2025View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Technology Officer
2,151$7.75$16.7K209,456Feb 18, 2025Feb 18, 2025View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
59,52559,525Feb 3, 2025Feb 4, 2025View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
90,475211,607Feb 3, 2025Feb 4, 2025View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Technology Officer
7,383$9.85$72.7K121,132Oct 16, 2024Oct 16, 2024View →
FATE
FATE THERAPEUTICS INC
SALE
Chief Technical Officer
3,418$5.24$17.9K123,705Jan 10, 2023Jan 11, 2023View →
FATE
FATE THERAPEUTICS INC
SALE
Chief Technical Officer
3,719$24.61$91.5K127,123Jul 5, 2022Jul 6, 2022View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
33,302130,842Jan 25, 2022Jan 27, 2022View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
53,05853,058Jan 25, 2022Jan 27, 2022View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
59,54097,540Nov 19, 2021Nov 22, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
38,00038,000Jun 14, 2021Jun 22, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
18,50018,500Jun 14, 2021Jun 22, 2021View →
Other insiders · FATE
Loading peer insiders…
About this filer
CIK 0001868719
ROLE
Chief Technical Officer
PRIMARY
FATE
COMPANIES
2
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001868719DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback